search

Active clinical trials for "Enterocolitis, Pseudomembranous"

Results 21-24 of 24

Antimicrobial Stewardship Program for Clostridium Difficile Infection.

Clostridium DifficileEnterocolitis1 more

The purpose of this study is to determine whether a bundle of measures specifically designed for patients with ICD and applied by and Infectious Diseases expert during a year period (2017) will improve the prognosis and reduce the rate of recurrence, compared with the baseline phase (2015) in which no intervention was made.

Completed4 enrollment criteria

Small Bowel Transit Time in Clostridium Difficile Colitis

Clostridium Difficile Colitis

Clostridium difficile is a bacteria that can infect the colon and cause severe diarrhea in patients after recent antibiotic use. The current standard of care treatment for severe C. diff. consists of oral vancomycin and/or intravenous metronidazole. When treatment is unsuccessful, it can lead to need for removal of the entire colon or even death. In fact, mortality rates in the literature range from 11-37% for C. diff. The most commonly quoted mortality rate is 14% for severe infection. It is believed that the failure of treatment may stem from an adynamic ileus (paralysis of the small bowel). This ileus may prevent the oral vancomycin from reaching the colon and therefore it does not treat the problem. Vancomycin functions by direct contact with the colon. It is presumed that this paralysis of the small intestine is present but has never been proven. The objective of the study is to prove that there is an adynamic ileus present in c. diff colitis and therefore lead to investigations into improved treatment.

Terminated14 enrollment criteria

Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin Antibody

Clostridium EnterocolitisPseudomembranous Colitis1 more

The purpose of this study is three fold: 1)To collect serum from patients with documented Clostridium difficile infection and test for the presence of antibody to C. difficile toxin at the start and at the end of therapy, and again if a relapse or recurrence occurs. 2)To collect stool samples for test of C. difficile toxin at similar time intervals. 3)To assay random serum samples from the VA lab in order to determine the rate of antibody to C. difficile toxin in our patient population.

Completed2 enrollment criteria

Fecal Bacterial Flora in Clostridium Difficile-Associated Diarrhea

EnterocolitisPseudomembranous Colitis1 more

The investigators propose to study intensively the bacteriology of feces in C. difficile associated diarrheal disease, using a variety of conventional and very up-to-date techniques.

Completed5 enrollment criteria

Need Help? Contact our team!


We'll reach out to this number within 24 hrs